BioCentury
ARTICLE | Company News

Angeliq approved in the Netherlands

December 18, 2002 8:00 AM UTC

The Netherlands granted marketing approval to Schering (FSE:SCH; SHR) for its Angeliq oral once-daily estradiol and drospirenone hormone replacement therapy (HRT) to treat menopausal symptoms and to p...